AUROBINDO PHARMA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,256 INR | +0.54% |
|
+0.34% | +15.83% |
| Jun. 05 | Hindalco-owned Novelis delays US IPO; shares slide | RE |
| May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 1,266.40 | 1,266.40 | 1,265.15 |
| Spread/Res. | -0.86% | -0.86% | -0.76% |
| Spread/Supp. | +5.89% | +12.58% | +25.39% |
| Support | 1,185.70 | 1,115.30 | 1,001.35 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- AUROPHARMA Stock
- Charts Aurobindo Pharma
